Joint Bridging Topic workshop: "Artificial intelligence in antibodies & vaccines development"

Save the date!

The advent of artificial intelligence (AI) has opened new opportunities for vaccine and antibody development. AI-driven approaches have for example the potential to rapidly advance the identification of immunogens and novel adjuvant candidates with optimal safety and efficacy profiles. 

To provide more insights into the transformative impact of AI on translation and product development driven activities, the Bridging Topics “Vaccines” and “Antibody-based Therapies” organize a joint Bridging Topic workshop. Participation in this workshop is open to all interested members of the DZIF as well as the extended scientific community. 

With this workshop, we aim to improve our knowledge in AI-supported development of safe and effective vaccines and antibodies, as well as foster interdisciplinary collaborations. This will be the first workshop related to AI and R&D within the DZIF Vaccine and Antibody Bridging Topics, emphasizing the ambition to further drive innovative AI technologies within the DZIF.

Language
English

Registration
Registration will open soon.
Deadline: 15 October 2025

Abstract submission
Deadline: 1 October 2025

Scientific organization
Coordinator of the Bridging Topic “Antibody-Based Therapies”:
Prof. Dr. Florian Klein
Coordinators of the Bridging Topic “Vaccines”:
Klaus Schwamborn, Ph.D.

Contact
Agnieszka Mitulski
Send an email

Susanne Salomon
Send an email